Leerink Partnrs Issues Negative Estimate for ACAD Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at Leerink Partnrs reduced their Q3 2025 earnings per share estimates for shares of ACADIA Pharmaceuticals in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now expects that the biopharmaceutical company will earn $0.15 per share for the quarter, down […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at Leerink Partnrs reduced their Q3 2025 earnings per share estimates for shares of ACADIA Pharmaceuticals in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now expects that the biopharmaceutical company will earn $0.15 per share for the quarter, down […]
